or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

[x] close
Print

Public Statements

Public Statements

Office

State

Issue

Limit results to

Keyword Search

Date Title Officials Location
May 15, 2013 Bennet, Burr, Harkin, Alexander Introduce Bill to Improve Safety of Nation's Drug Supply Sen. Thomas Harkin Unknown
May 6, 2013 Letter to Dr. Margaret Hamburg, Commissioner for the U.S. Food and Drug Administration - End Infant Drug Shortage Sen. Thomas Harkin Unknown
April 26, 2013 Harkin, Alexander, Franken, Roberts Release Draft Bill to Make Clear Oversight Responsibilities for Pharmaceutical Compounding, Ensure Safety for Consumers Sen. Thomas Harkin Washington, DC
April 26, 2013 Senators Lautenberg, Durbin, Harkin, and Blumenthal Introduce Legislation to Stop Tobacco Smuggling, Close Tobacco Tax Loopholes, and Increase Federal Tobacco Taxes Sen. Thomas Harkin Washington, DC
April 18, 2013 GAO Report on Caribbean Anti-Drug Trafficking Programs Sen. Charles Grassley Unknown
April 11, 2013 Feinstein, Grassley Introduce Bill to Combat Transnational Organized Crime Sen. Charles Grassley Washington, DC
March 22, 2013 Letter to Food and Drug Administration (FDA) Commissioner Margaret Hamburg - Develop Tobacco Warning Labels Sen. Thomas Harkin Washington, DC
Feb. 13, 2013 New GAO Report on Meth Ingredient Restrictions Sen. Charles Grassley Unknown
Feb. 5, 2013 Klobuchar, Grassley Reintroduce Legislation to Crack Down on Anti-Competitive Pay-for-Delay Deals Sen. Charles Grassley Washington, DC
Oct. 19, 2012 Rozga Family Receives Anti-drug Advocacy Role from White House Sen. Charles Grassley Unknown
Sept. 21, 2012 Senators Blumenthal, Kohl, Grassley Seek to Protect the Elderly and Taxpayers from Abusive Overprescribing of Antipsychotics Sen. Charles Grassley Washington, DC
July 26, 2012 National Crackdown on Synthetic Drugs Sen. Charles Grassley Unknown
June 25, 2012 Food and Drug Administration Safety and Innovation Act Sen. Charles Grassley Washington, DC
June 20, 2012 Latham-Sponsored Measure Cracking Down on Synthetic Drugs Gains Momentum in Congress Rep. Thomas Latham Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. Thomas Latham Washington, DC
June 12, 2012 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy &Commerce, The Honorable Tom Harkin, Chairman of the Committee on Health, Education, Labor &Pensions, and the Honorable Henry A. Waxman, Ranking Member of the Committee on Energy and Commerce, The Honorable Michael B. Enzi, Ranking Member of the Committee on Health, Education, Labor & Pensions Rep. David Loebsack Washington, DC
June 8, 2012 Letter to Chairman Harkin, Ranking Member Enzi, Chairman Upton, and Ranking Member Waxman Sen. Charles Grassley Washington, DC
June 7, 2012 Grassley, Feinstein Release Report on Drug Demand Reduction Strategies Sen. Charles Grassley Washington, DC
May 24, 2012 Food and Drug Administration Safety and Innovation Act Sen. Thomas Harkin Washington, DC
May 24, 2012 Senate Passes Grassley Bill to Ban Dangerous Synthetic Drugs Sen. Charles Grassley Washington, DC
May 23, 2012 Food and Drug Administration Safety and Innovation Act--Motion to Proceed--Resumed Sen. Charles Grassley Washington, DC
May 23, 2012 Leahy-Grassley Bill to Increase Penalties for Counterfeit Drugs Adopted in FDA Bill Sen. Charles Grassley Unknown
May 23, 2012 The Hill - Passing FDA Bill Will Save Lives Sen. Thomas Harkin Unknown
May 22, 2012 Kohl, Grassley and Blumenthal Seek to Cut Misuse of Antipsychotics Sen. Charles Grassley Washington, DC
May 17, 2012 The Food and Drug Administration Safety and Innovation Act--Motion to Proceed--Continued Sen. Thomas Harkin Washington, DC
May 16, 2012 Hearing of the Senate Caucus on International Narcotics Control - Drug Trafficking in West Africa Sen. Charles Grassley Unknown
May 2, 2012 Senators Respond to New Data on Tobacco Tax Loophole Sen. Thomas Harkin Washington, DC
April 23, 2012 Letter to Daniel Inouye and Thad Cochran, Chairman and Ranking Member of the Defense Subcommittee of the Senate Committee on Appropriations Sen. Charles Grassley Washington, DC
March 29, 2012 Senate Judiciary Committee Approves Leahy, Grassley Bill to Reauthorize Drug Free Communities Program Sen. Charles Grassley Washngton, DC
March 22, 2012 Hearing of the Health Subcommittee of the Senate Finance Committee - Prescription Drug Abuse: How are Medicare and Medicaid Adapting to the Challenge? Sen. Charles Grassley Washington, DC
March 22, 2012 Hearing of the Health Care Subcommittee of the Senate Finance Committee - Prescription Drug Abuse: How are Medicare and Medicaid Adapting to the Challenge? Sen. Charles Grassley Washington, DC
March 21, 2012 Cummings, Rockefeller, and Harkin Investigate "Fake Pharmacies" Buying and Selling Shortage Drugs in the Gray Market Sen. Thomas Harkin Washington, DC
March 19, 2012 Q&A on Medical Device Safety Sen. Charles Grassley Unknown
March 8, 2012 Senators: Surgeon General's Report on Youth Smoking Epidemic a Call to Action For State and Federal Government Sen. Thomas Harkin Washington, DC
March 7, 2012 Senate Approves Leahy-Grassley Bill to Increase Penalties for Counterfeit Drugs Sen. Charles Grassley Washington, DC
March 7, 2012 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration Sen. Thomas Harkin Hartford, CT
March 6, 2012 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington, DC
March 6, 2012 Leahy, Grassley Introduce Bill to Reauthorize Drug Free Communities Program Sen. Charles Grassley Washington, DC
March 5, 2012 Grassley, Enzi, Hatch, Pitts Seek Details of Discount Drug Program Sen. Charles Grassley Washington, DC
Feb. 23, 2012 In Iowa's Interest: New Data Proves Affordable Care Act is Saving Iowans on Prescription Drug Costs Sen. Thomas Harkin Unknown
Feb. 17, 2012 Letter to George Doyle III, President and Chief Operating Officer of Ben Venue Laboratories Sen. Thomas Harkin Washington, DC
Feb. 15, 2012 Synthetic Drug Use Sen. Charles Grassley Washington, DC
Dec. 23, 2011 Q&A on Payments from Drug Companies and Medical Device Makers Sen. Charles Grassley Unknown
Dec. 16, 2011 Feinstein, Grassley Bill to Combat Transnational Organized Crime Passes the Senate Sen. Charles Grassley Washington, DC
Dec. 15, 2011 Grassley: Objection to Synthetic Drug Ban Bill is Unjustified Sen. Charles Grassley Unknown
Dec. 15, 2011 Senate Chairmen Join Cummings' Investigation of "Gray Market" Drug Companies Sen. Thomas Harkin Washington, DC
Dec. 7, 2011 Synthetic Drug Control Act of 2011 Rep. Thomas Latham Washington, DC
Dec. 6, 2011 Iowa Family's Tragedy Helps Spark U.S. Congressional Action on Synthetic Drugs Rep. Thomas Latham Washington, DC
Dec. 1, 2011 Letter to Ian Read, President and Chief Executive Officer Pfizer Inc. Sen. Charles Grassley Unknown
Dec. 1, 2011 Letter to Dr. Margaret Hamburg, Commissioner, Food and Drug Administration Sen. Thomas Harkin Unknown
Nov. 21, 2011 Q&A on Medicare open enrollment Sen. Charles Grassley Unknown
Nov. 17, 2011 Proposal for Bipartisan, Bicameral Bill To Increase Penalties For Counterfeit Drugs Sen. Charles Grassley Washington, DC
Nov. 17, 2011 Meehan Introduces Bill Boosting Penalties for Rx Drug Counterfeiting Sen. Charles Grassley Washington, DC
Nov. 16, 2011 Hearing of the Senate Judiciary Committee - Nominations Sen. Charles Grassley Washington, DC
Nov. 9, 2011 Agency Confirms Poor Oversight of Federal Discount Drug Program Sen. Charles Grassley Washington, DC
Nov. 8, 2011 Kohl-Grassley Generic Drug Bill Would Save Taxpayers Nearly $4.8 Billion, Congressional Budget Office Says Sen. Charles Grassley Washington, DC
Oct. 25, 2011 Dealmaking in Pay-for-Delay Settlements Continues between Brand Name and Generic Prescription Drug Makers Sen. Charles Grassley Washington, DC
Oct. 14, 2011 Letter to Co-Chairmen Murray and Hensarling of the Joint Select Committee on Deficit Reduction Rep. Thomas Latham Washington, DC
Oct. 14, 2011 Letter to Senator Murray and Representative Hensarling Sen. Charles Grassley Washington, DC
Oct. 14, 2011 Letter to Co-Chairmen Murray and Hensarling of the Joint Select Committee on Deficit Reduction Rep. Bruce Braley Washington, DC
Oct. 5, 2011 Letter to Co-Chairs and Members of the Joint Select Committee on Deficit Reduction Rep. Bruce Braley Washington, DC
Oct. 5, 2011 Letter to The Honorable Kathleen Sebelius U.S. Department of Health and Human Services Sen. Charles Grassley Washington, DC
Sept. 27, 2011 Feinstein, Grassley Designate October "National Medicine Abuse Awareness Month' Sen. Charles Grassley Washington, DC
Sept. 26, 2011 Feinstein, Grassley Introduce Bill to Combat Transnational Organized Crime Sen. Charles Grassley Washington, DC
Sept. 8, 2011 Leahy-Smith America Invents Act Sen. Charles Grassley Washington, DC
July 30, 2011 Grassley Bill to Ban Synthetic Drug Advances via Committee Sen. Charles Grassley Washington DC
July 26, 2011 ATF Officials in Mexico Denied Access to Information by U.S. Counterparts about Reckless Strategy that Allowed Guns to Fall Into the Hands of Mexican Drug Cartels Sen. Charles Grassley Washington, DC
July 21, 2011 Judiciary Committee Approves Kohl-Grassley Bill to Save Billions by Stopping 'Payoffs' that Hinder Competition from Generic Drugs Sen. Charles Grassley Washington, DC
July 21, 2011 udiciary Committee Approves Kohl-Grassley Bill to Save Billions by Stopping "Pay-offs" That Hinder Competition from Generic Drugs Sen. Charles Grassley Washington DC
July 18, 2011 Grassley, Issa Press for Answers from FBI, DEA in Fast and Furious Investigation Sen. Charles Grassley Washington DC
July 15, 2011 Letter to The Honorable Michele M. Leonhart, Administrator, United States Drug Enforcement Administration Sen. Charles Grassley Washington, DC
June 20, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington DC
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration Sen. Thomas Harkin Washington, DC
June 16, 2011 Letter to The Honorable John Boehner, Speaker of the US House of Representatives Rep. David Loebsack Washington, DC
June 16, 2011 Letter to The Honorable John Boehner, Speaker of the US House of Representatives Rep. Bruce Braley Washington, DC
June 15, 2011 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012 Rep. Steve King Washington, DC
May 25, 2011 Baucus, Grassley Report Details Financial Relationship Between Drug Company, Physicians Who Lobbied the FDA Sen. Charles Grassley Washington, DC
May 9, 2011 Grassley, Kohl: Nursing Home Residents Receive Powerful Antipsychotic Drugs for Off-label Uses, Inspector General Report Shows Sen. Charles Grassley Washington, DC
May 5, 2011 Important Points for America to Consider Rep. Steve King Washington, DC
May 5, 2011 Letter to Influential Disease and Medical Advocacy Groups Sen. Charles Grassley Washington, DC
April 14, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington, DC
March 30, 2011 Harkin Calls on Drug Manufacturer to Lower Price of Makena Sen. Thomas Harkin Washington, DC
March 17, 2011 Feinstein Introduces Bill to Ban Chemicals Used in Synthetic Drugs Sen. Charles Grassley Washington, DC
March 17, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington, DC
March 10, 2011 Letter to Margaret Hamburg, Commissioner of the Food and Drug Administration Sen. Thomas Harkin Washington, DC
March 8, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington, DC
March 2, 2011 Statements on Introduced Bills and Joint Resolutions Sen. Charles Grassley Washington, DC
Feb. 11, 2011 Q & A: Helping Communities Fight Illegal Drugs Sen. Charles Grassley Unknown
Jan. 26, 2011 Kohl, Grassley: Stopping"Pay-for-Delay" Deals Essential to Lowering RX Drug Costs Sen. Charles Grassley Washington, DC
Jan. 21, 2011 Harkin: Health Reform Has Delivered Prescription Drug Relief to Nearly 40,000 Iowans Sen. Thomas Harkin Washington, DC
Jan. 4, 2011 Q & A: A Healthy Dose of Disclosure Sen. Charles Grassley Unknown
Dec. 23, 2010 Q & A: A Healthy Dose of Disclosure Sen. Charles Grassley Unknown
Dec. 22, 2010 Youth Drug Use Sen. Charles Grassley Washington, DC
Dec. 17, 2010 Harkin, Bennet Applaud Dingell Drug Safety Bill Sen. Thomas Harkin Washington, DC
Nov. 19, 2010 Sunshine: Best Rx for Good Medicine Sen. Charles Grassley Unknown
Nov. 18, 2010 Illegal Immigration Rep. Steve King Washington, DC
Oct. 27, 2010 2500 First District Seniors Receive Checks to Cover Costs of "Donut Hole" Rep. Bruce Braley Washington, DC
Sept. 22, 2010 K2 Products Sen. Charles Grassley Washington, DC
Aug. 27, 2010 Statement on GAO'S Clinical Trials Report Sen. Charles Grassley Washington, DC
Aug. 4, 2010 Secure and Responsible Drug Disposal Act of 2010 Passes Senate Sen. Charles Grassley Washington, DC

About Project Vote Smart

Help Us If You Can

Media & Communications

Education

For Candidates

One Common Ground, Philipsburg, MT 59858 Hotline: 888-Vote-Smart (888-868-3762)
All content © 1992 - 2013 Project Vote Smart unless otherwise attributed - Privacy Policy - Legislative demographic data provided by Aristotle International, Inc. Mobile Version

Back to top